VICTOR BUI: Open Payments
NPI 1871187443 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,259 in 278 payments from 20 companies in 2025. Trend: 2023 $4,614 · 2024 $4,495 · 2025 $5,259
Food & beverage: $5,259
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 26 | $751 |
| Axsome Therapeutics, Inc. | 15 | $522 |
| Otsuka America Pharmaceutical, Inc. | 24 | $463 |
| Vanda Pharmaceuticals Inc. | 16 | $421 |
| Teva Pharmaceuticals USA, Inc. | 23 | $411 |
| E.R. Squibb & Sons, L.L.C. | 24 | $403 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $394 |
| ABBVIE INC. | 24 | $307 |
| Supernus Pharmaceuticals, Inc. | 19 | $300 |
| Alkermes, Inc. | 17 | $281 |
Products named: INGREZZA, Auvelity, FANAPT, COBENFY, REXULTI, CAPLYTA, Qelbree, VRAYLAR.
Industry payments across TX — which companies pay providers there.
